Skip to content

Public FDA record

Z-0043-05: The MDA system with MDA Antithrombin III MDA Heparin

Recall record Z-0043-05 for bioMerieux. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0043-05
Company in FDA record
bioMerieux
FDA classification date
Oct 23, 2004
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

The firm received complaints regarding an observed bias in percent activity between capped and uncapped specimens.

Source facts

Action
Consignees were initially notified by letter on June 11, 2004. A follow up letter was sent to consignees, via Fedex on July 9, 2004.
Initiated
2004-06-11
Root cause
Other
Terminated
2005-06-07
Distribution
Nationwide, Australia, Belgium, Brazil, Canada, China, Germany, Italy, Japan, Taiwan, UK
Recall number
Z-0043-05
Recall status
Terminated
CDRH record ID
35030
FDA classified
2004-10-23
Recall event number
30026

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗